Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 11Lung Neoplasms 7Colonic Neoplasms 5Pancreatic Neoplasms 3Pain, Postoperative 3Inflammatory Bowel Diseases 3Diverticulitis 3Carcinoma, Hepatocellular 3Urinary Bladder Neoplasms 2Male Urogenital Diseases 2Leiomyoma 2Inflammation 2Carcinoma, Non-Small-Cell Lung 2Agnosia 2Abdominal Cancer 2Unspecified Adult Solid Tumor, Protocol Specific 1Thyroid Neoplasms 1Stomatitis 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Smoking Cessation 1Skin Neoplasms 1Shoulder Pain 1Respiration Disorders 1Psychological Well-Being 1Postoperative Complications 1Post-thoracotomy Pain Syndrome 1Pleural Diseases 1Neoplasms 1Mouth Neoplasms 1

Interventions

padeliporfin 5Lycopene 3Vitamin E 2Tea 2Selenium 2Cholecalciferol 2relatlimab 1pembrolizumab 1palladium-bacteriopheophorbide 1Therapeutics 1Surveys and Questionnaires 1Sugars 1Nivolumab 1Intraoperative Neurophysiological Monitoring 1CP protocol 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Male Urogenital Diseases × Tea × Clear all
NCT00744549 2018-02-14

Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance

University Health Network, Toronto

Phase 2 Completed
16 enrolled
Genitourinary

Prostatic Neoplasms, Male Urogenital Diseases

NCT00844792 2017-10-26

Study of Antioxidants on Prostate Tumors in Men Undergoing Radical Prostatectomy for Prostate Cancer

University Health Network, Toronto

Phase 2 Completed
48 enrolled
Genitourinary

Prostatic Neoplasms, Male Urogenital Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡